Corporate Banner
Satellite Banner
RNAi
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - November 2013


EMBL Conference: Genome Editing Using Zinc Finger Nucleases

14 Nov 2013 - 15 Nov 2013 - EMBL Heidelberg, Germany



Bookmark and Share


Zinc finger nucleases (ZFNs) enable manipulation of the genome with unprecedented ease and precision. ZFNs are a class of engineered DNA-binding proteins that facilitate targeted editing of the genome by creating double-strand breaks in DNA at user-specified locations. ZFNs have already been used to generate targeted genomic deletions of large segments of DNA in different cell types and organisms like mouse and human cells, plants, fruit flies, zebrafish, and rat. Recently, ZFNs have been used to disrupt or tag genes in human pluripotent stem cells, a system of tremendous interest for genome engineering that was lacking a reliable gene manipulation tool. Featuring keynote presentations, this conference will allow participants to discover the latest applications of transgenics and cell based models for the study of gene regulation and disease. Comprehensive lectures provide in-depth discussion on the fundamentals of ZFNs as well as innovative applications for targeted gene knockout, integration, and tagging. Geared towards scientists interested in learning about the technology, the conference provides researchers at all levels with a unique opportunity for networking with peers. Discussions will facilitate the exchange of ideas to shape the future directions of research in this key area.

Topics

  • Gene tagging
  • Genome editing in stem cells
  • Transgenic animal models
  • Gene knockout
  • Recent advances in ZFN technology



Further information
Scientific News
Detection of HPV in First-Void Urine
Similar sensitivity of HPV test on first void urine sample compared to cervical smear.
Potential “Good Fat” Biomarker
New method to measure the activity of energy consuming brown fat cells could ease the testing weight loss drugs.
Shape Of Tumor May Affect Whether Cells Can Metastasize
Illinois researchers found that the shape of a tumor may play a role in how cancer cells become primed to spread.
MicroRNA Pathway Could Lead to New Avenues for Leukemia Treatment
Cancer researchers at the University of Cincinnati have found a particular signaling route in microRNA (miR-22) that could lead to targets for acute myeloid leukemia, the most common type of fast-growing cancer of the blood and bone marrow.
Analysis of Dog Genome will Provide Insight into Human Disease
An important model in studying human disease, the non-coding RNA of the canine genome is an essential starting point for evolutionary and biomedical studies – according to a new study led by The Genome Analysis Centre (TGAC).
New Blood Test for The Earlier Diagnosis of Breast Cancer Spread
Researchers at University of Westminster have confirmed that a new blood test can detect if breast cancer has spread to other parts of the body.
First Gene Therapy Successful Against Human Aging
American woman gets biologically younger after gene therapies.
Targeting an ‘Undruggable’ Cancer Gene
RAS genes are mutated in more than 30 percent of human cancers and represent one of the most sought-after cancer targets for drug developers.
Altered Metabolism of Four Compounds Drives Glioblastoma Growth
Findings suggest new ways to treat the malignancy, slow its progression and reveal its extent more precisely.
Improving Engineered T-Cell Cancer Treatment
Purdue University researchers may have figured out a way to call off a cancer cell assassin that sometimes goes rogue and assign it a larger tumor-specific "hit list."
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,400+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!